PINK Stock: Simplify Health Care ETF Profile & Analysis (2026)
An actively managed healthcare strategy focused on medical innovation, biotech growth, and cost-efficient business models — Updated May 2026 with current AUM, expense ratio, holdings, and performance data.
The Simplify Health Care ETF (PINK) is a uniquely structured, actively managed exchange-traded fund that targets the most innovative segments of the U.S. healthcare sector. Unlike passive funds that simply track an index, PINK relies on the expertise of portfolio manager Michael Taylor to identify companies developing breakthrough medicines or disruptive technologies. The fund focuses on a high-conviction portfolio of 50 to 100 names, emphasizing firms that improve patient outcomes while reducing systemic costs.
While many investors look toward the complete list of semiconductor companies to find the engines of the digital economy, PINK seeks the engines of the biological economy. This active approach results in a significantly higher turnover rate than broader sector funds, as the manager aggressively rotates positions based on clinical trial results and regulatory shifts. Additionally, PINK is notable for its philanthropic mission, as Simplify Asset Management has historically committed to donating a portion of the fund’s management fee to breast cancer research, aligning financial goals with social impact.
Key Takeaways — PINK Stock
Managed by Michael Taylor, the fund seeks alpha by picking individual healthcare winners rather than owning the entire market cap-weighted sector.
With an annual turnover rate exceeding 200%, the fund frequently adjusts its holdings to capitalize on short-term catalysts and medical breakthroughs.
The portfolio prioritizes biotech and medical tech companies over legacy healthcare providers and insurers with stagnant growth models.
The PINK ticker represents more than a sector; the fund supports breast cancer research through Simplify’s philanthropic fee-sharing initiatives.
PINK — Live Price Chart
Real-time chart from TradingView.
PINK ETF Vitals & Key Statistics
Core data as of May 2026.
| Data Point | Value | Data Point | Value |
|---|---|---|---|
| Full Name | Simplify Health Care ETF | Ticker | PINK |
| Issuer | Simplify Asset Management | Asset Class | U.S. Equity — Health Sector |
| Index Tracked | None (Actively Managed) | Structure | Open-Ended Fund |
| Expense Ratio | 0.50% | AUM | ~$254.36M |
| Inception Date | October 7, 2021 | Exchange | AMEX |
| No. of Holdings | 53 | Dividend Yield | 0.15% |
| 52-Week High | $37.95 | 52-Week Low | $37.95 |
| Avg Daily Volume | $264K | YTD Return | 11.20% |
| 1-Year Return | 18.45% | 5-Year Return | N/A (Active) |
| Category | Healthcare Equities | Dividend Frequency | Quarterly |
PINK Top 10 Holdings (May 2026)
Largest positions by weight. Click columns to sort.
| Rank | Ticker | Company Name | Sector | Weight % |
|---|---|---|---|---|
| 1 | PCT | PureCycle Technologies | Industrials/Health | 10.13% |
| 2 | UTHR | United Therapeutics | Biotechnology | 7.65% |
| 3 | NVO | Novo Nordisk | Pharmaceuticals | 6.80% |
| 4 | LLY | Eli Lilly and Company | Pharmaceuticals | 5.39% |
| 5 | JNJ | Johnson & Johnson | Healthcare | 5.27% |
| 6 | MRK | Merck & Co. | Pharmaceuticals | 4.50% |
| 7 | ABBV | AbbVie Inc. | Biotechnology | 4.20% |
| 8 | TMO | Thermo Fisher Scientific | Medical Devices | 3.90% |
| 9 | ISRG | Intuitive Surgical | Medical Tech | 3.65% |
| 10 | VRTX | Vertex Pharmaceuticals | Biotechnology | 3.20% |
PINK — Pros & Cons
✓ Skilled Active Selection
The ability to overweight breakthrough biotech like Eli Lilly while avoiding legacy laggards offers potential outperformance.
✗ High Turnover Costs
A turnover rate above 200% can lead to higher transaction costs and potential tax inefficiencies for non-sheltered accounts.
✓ Innovation Exposure
Provides targeted exposure to next-gen medical solutions, similar to how tech investors use a complete list of food & beverage companies to find wellness innovators.
✗ Manager Risk
The performance is heavily dependent on Michael Taylor’s individual calls; if the manager exits or makes poor timing choices, the fund may suffer.
✓ Philanthropic Mission
Investors can support breast cancer research through the fund’s unique fee-donation structure without sacrificing equity exposure.
✗ Higher Expense Ratio
At 0.50%, it is significantly more expensive than passive alternatives like XLV or VHT which charge less than 0.10%.
Who Should Consider PINK?
Growth-oriented investors who want professional active management to navigate the complex regulatory and clinical environment of healthcare.
Passive “buy and hold” investors who prioritize the lowest possible expense ratios and minimal portfolio turnover.
You are looking for a high-conviction medical sleeve to complement broader holdings in publicly traded sports companies or general consumer staples.
Ideal for IRAs or 401(k)s where the high turnover won’t trigger immediate capital gains tax consequences for the investor.
PINK vs Similar ETFs
Key metrics comparison.
| ETF | Full Name | Expense Ratio | AUM | Holdings | Div Yield | YTD | Best For |
|---|---|---|---|---|---|---|---|
| PINK ★ | Simplify Health Care ETF | 0.50% | $254.36M | 53 | 0.15% | 11.20% | Active Alpha |
| XLV | Health Care Select Sector SPDR | 0.09% | $38B+ | ~65 | 1.55% | 8.10% | Passive Core |
| VHT | Vanguard Health Care ETF | 0.10% | $17B+ | ~400 | 1.30% | 7.95% | Broad Market |
| FHLC | Fidelity MSCI Health Care ETF | 0.08% | $3B+ | ~380 | 1.25% | 8.05% | Lowest Cost |
PINK Technical Analysis
Real-time buy/sell signals.
PINK — Risks & Considerations
High Turnover Risk
The 201% turnover rate means the portfolio you buy today could be entirely different in six months, requiring trust in the manager’s agility.
Concentration Risk
By holding only ~50 names, the fund is more susceptible to single-stock volatility than broad-market healthcare ETFs holding 400+ names.
Active Performance Gap
Active management does not guarantee outperformance; the fund may underperform the S&P 500 Healthcare index if the manager’s calls are incorrect.
Regulatory Sensitivity
Healthcare stocks are uniquely sensitive to U.S. government policy changes regarding drug pricing and insurance mandates.